跳至主要内容
临床试验/NL-OMON50744
NL-OMON50744已完成不适用

Metabolic state and survival in patients with amyotrophic lateral sclerosis - MEASURE

Afdeling Neurologie0 个研究点目标入组 234 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
234

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • For patients only (N = 78): meeting the El Escorial criteria for definite,
  • probable, probable laboratory supported or possible ALS, For controls only (N =
  • 78): diagnosis with neurological syndrome within the range of peripheral
  • polyneuropathies with sensorimotor or motor fiber involvement. Or other motor
  • neuron disease (primary lateral sclerosis, progressive muscular atrophy,
  • progressive bulbar palsy or pseudobulbar palsy) , Asymptomatic carriers and
  • family members (N = 2x39): absence of any neurological symptom associated with
  • ALS., For family members, non-carriers and carriers, of any related gene to
  • ALS: absence of any neurological symtpoms associated with ALS. , All subjects:
  • >= 18 years of age

排除标准

  • All subjects:
  • 1.2. Participants < 18 years of age
  • 2.3. Participants are not able to lay down for at least one hour, without any
  • difficulties of swallowing or breathing.
  • 3.4. Participants with tracheostomy or other assisted ventilation in the
  • preceding 3 months., Neurological Controls, asymptomatic carriers, carriers of
  • any other gene related to ALS and family members of ALS patients with a
  • suspected genetic background of ALS (familial ALS):
  • 7.6. Patients with peripheral polyneuropathy with only sensory fiber
  • involvement (i.e. human immunodeficiency virus or vitamin B5 toxicity)
  • 8.7. Patients with peripheral mononeuropathy (i.e. compression or entrapment
  • neuropathies)

研究者

发起方
Afdeling Neurologie

相似试验